期刊文献+

加味柴胡疏肝散治疗痛性糖尿病周围神经病变35例 被引量:4

Treatment of 35 Cases of Diabetic Painful Neuropathy by Modified Chaihu Shugan Powder
下载PDF
导出
摘要 目的 :观察加味柴胡疏肝散治疗痛性糖尿病周围神经病变的临床疗效。方法 :70例痛性糖尿病周围神经病变患者按随机数字表法分为治疗组和对照组,入组后对所有患者用视觉模拟评分法(VAS)对疼痛进行评估。治疗组予以加味柴胡疏肝散治疗,对照组予以盐酸度洛西汀60 mg/d。疗程为1周,治疗结束后比较两组患者治疗效果。结果:VAS疗效比较:与用药前相比,两组患者用药后1,2,3个月VAS均显著下降(P<0.01),用药后两组间同时间比较,有显著性差异(P<0.05),治疗组优于对照组(P<0.05)。结论 :加味柴胡疏肝散可有效治疗痛性糖尿病周围神经病变。 Objective:To observe the curative effect of modified Chaihu Shugan Powder on diabetic painful neuropathy. Methods:Seventy patients with diabetic painful neuropathy were divided into treatment group and control group by random number table. The pain degree of all patients were evaluated by VAS when they were included in the study. The treatment group was treated by modified Chaihu Shugan Powder and the control group was given duloxetine hydrochloride ,60 mg/d. The treatment course was 1 week. The curative effects of the two groups were compared after treatment. Results:In the first,second and third month after treatment,the scores of VAS of the two groups all significantly decreased (P&lt;0.01). After treatment,there was statistical difference between the curative effects of the two groups (P&lt;0.01). There was significant dif-ference between the two groups (P&lt;0.05). The curative effect of the treatment group was better than that of the control group (P&lt;0.05). Conclusion:Modified Chaihu Shugan Powder can improve the curative effect on diabetic painful neuropathy.
出处 《山东中医杂志》 2015年第8期584-586,共3页 Shandong Journal of Traditional Chinese Medicine
基金 国家中医药管理局全国名老中医药专家传承工作室建设项目
关键词 痛性糖尿病周围神经病变 肝郁化火兼血瘀型 柴胡疏肝散 diabetic painful neuropathy fire derived from stagnation of liver and blood stasis syndrome Chaihu Shugan Powder
  • 相关文献

参考文献5

二级参考文献26

  • 1Wong DT,Bymaster FP.Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype ? Prog Drug Res,2002,58:169-222.
  • 2Philip AL.The mechanism of diabetic neuropathy∥Kalhn CR.Joslin′s Diabetes Mellitus.14th ed.Lippincott,Williams and Wilkins,Awolters Kluwer Company,Philadelphia,New York,London,2004:14.
  • 3Ren K,Dubner R.Descending modulation in persistent pain:an update.Pain,2002,100(1/2):1-6.
  • 4Basbaum AI,Fields HL.Endogenous pain control systems:brainstem spinal pathways and endorphin circuitry.Annu Rev Neurosci,1984,7:309-338.
  • 5Millan MJ.Descending control of pain.Prog Neurobiol,2002,66(6):355-474.
  • 6Coderre TJ,Katz J.Peripheral and central hyperexcitability:differential signs and symptoms in persistent pain.Behav Brain Sci,1997,20(3):404-419;discussion 435-513.
  • 7劭福源,赵瑛,赵忠新.糖尿病性神经病变,糖尿病慢性并发症.上海:上海医科大学出版社,1999.
  • 8Amos AF,McCarty DJ,Zimmet P.The rising global burden of diabetes and its complications:estimates and projections to the year 2010.Diabetes Med,1997,14 Suppl 5:S1-S85.
  • 9Huskisson EC. Visual analogue scale[ M ] .//Melzack R. pain measure- ment and assessment. New York: Raven press, 1999:33.
  • 10Khan GM, Chen SR, Pan IlL. Role d" primary afferent nerves in allodyni- a caused by diabetic neureputhy in rats[J]. Neuroscience, 2002,114(2) : 291.

共引文献27

同被引文献64

引证文献4

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部